National Institute of Neurological Disorders and Stroke focuses on solving mysteries of the brain and nervous system to improve health. Self-described as an official government organization in the United States.

National Institute of Neurological Disorders and Stroke

Biotechnology Research

The National Institutes of Health

Government Administration

NINDS Small Business Programs

National Institute of Neurological Disorders and Stroke (NINDS) | 54,261 followers on LinkedIn. Our mission is to seek knowledge about the brain and nervous system and reduce the burden of neurological disease. | Privacy Notice &amp; Comment Policy

Medical Disclaimer: The advice provided through the NINDS LinkedIn page is for informational purposes only and is not a substitute for professional medical advice. You should consult a healthcare provider in all matters relating to your health.

Commenting Guideline: Please be aware that your comment may be removed if it contains material that is offensive, commercial, or unrelated to this page.

Michael Oshinsky

Director Of Bioinformatics at National Institute of Neurological Disorders and Stroke (NINDS)

Kory R. Johnson, MS, Ph.D.

Amir Tamiz

Neuroscientist, Entrepreneur, & Innovator | MedTech & HealthTech

Elyse Kemmerer White, Ph.D.

National Institute of Neurological Disorders and Stroke (NINDS)

In 2020-2021, NIH Blueprint supported the development and implementation of a short course focused on best-practices and common challenges associated with neural medical device development and translation. The program was a collaborative effort among four investigators from the University of Minnesota, Florida International University, and University of Colorado Denver and featured a series of video lectures and an annual workshop. #NIHBlueprint20

📢 Call for Nominations: Join the IPRCC! 📢 The Interagency Pain Research Coordinating Committee (IPRCC) is now accepting nominations for new members! We’re seeking passionate scientific and public members to contribute to national pain research priorities and improve outcomes for those affected by pain. If you or someone you know is dedicated to advancing pain research, we encourage you to apply! 🗓 Deadline: December 17th, 2024 📑 More info & application details: https://lnkd.in/eFK_-5Xc Help shape the future of pain research—submit your nomination today!

Are you working on innovative, non-addictive pain treatments? Join us for a Webinar on the HEAL Pain Therapeutics Development Program (PTDP)! This webinar aims to inform and answer participants’ questions on the HEAL Pain Therapeutics Development Program (PTDP) and the funding announcement RFA-NS-24-019. Register now: bit.ly/3Alo2AU

Want to accelerate your groundbreaking research in neurological disorders? Join us for a webinar on the NINDS IGNITE Program, a suite of funding opportunities for early-stage translational research. Learn how to secure funding for your innovative ideas, navigate the application process, and get expert tips from NINDS program directors. Register now: https://go.nih.gov/wn6buXa

🎙️#NINDSNervePod Season 5 Episode 4 is OUT NOW! Strengthen your science communication skills with tips and advice for "Crafting Effective Presentations" with special guests Alfredo Quiñones-Hinojosa, Alicia Wooten, and Huda Zoghbi #NINDSSciComm Episode 4 focuses on how presentations are used in traditional science communication and how to effectively present in different forms and venues, with accessibility built in by design. Listen to the episode: https://lnkd.in/eebUi4sQ Watch the episode with ASL interpretation: https://lnkd.in/egpmCSM5

The Neuroscience Research Opportunities to Increase Diversity (NeuroID) program, funded by the NIH Blueprint Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (ENDURE), has played a transformative role within The University of Puerto Rico-Rio Piedras by: • Establishing a comprehensive and innovative program to guide dozens of Hispanic students toward graduate programs in neuroscience • Fostering a robust mentorship network that supports students throughout their journey to become neuroscientists • Strengthening the neuroscience network in Puerto Rico by bridging the gap between undergraduate teaching universities and research labs across the United States For more information about this impactful program, please read the full article in the Journal of Undergraduate Neuroscience Education: https://lnkd.in/eGZRJ3XK

The NINDS Circuit is intended to keep the neuroscience community up to date on the latest NINDS research highlights, funding opportunities, office spotlights, meetings and events, and news from the NINDS Director. Please subscribe to stay connected!

🗓️Planning ahead for #ABRCMS2024 ? Several NINDS Staff members are heading to Pittsburgh for the Annual Biomedical Research Conference for Minoritized Scientists (ABRCMS)! You’ll have a chance to meet Dr. Michelle Jones-London, Dr. Marguerite Matthews, and Dr. Anahid Ebrahimi in the NINDS Office of Programs to Enhance the Neuroscience Workforce (OPEN), and Ms. Sheniece Guest in the NINDS Intramural Office of Research Training and Career Development. Stop by the NINDS booth (#1428) to meet our team and learn about NIH diversity training grants and research opportunities. And save the date to join NINDS's Dr. Sadhana Jackson and NIH colleagues for "The Joys of Science Research – Connecting Basic, Translational and Clinical Sciences" which will take place Nov 14, 2024 from 3:45 – 4:15 pm ET in the David L. Lawrence Convention Center, Exhibit Hall Theater (Aisle 300).

You Have a Brilliant Mind. Don’t Risk Losing it to High Blood Pressure Many years before you have a stroke or notice dementia, uncontrolled high blood pressure narrows your arteries, decreasing blood to your brain. Take charge of your health today because nobody else can lower your risk of stroke and dementia like you can. For more information, visit: mindyourrisks.nih.gov

Interested in accelerating your small molecule drug discovery and development project? Join us for a Q&A Webinar on the Blueprint Neurotherapeutics Network for Small Molecules (BPN-Small Molecule) program. Learn how the BPN-Small Molecule program can provide non-dilutive support to advance your project from hit-to-lead chemistry through Phase I clinical testing. Register now: bit.ly/3C6t4BE

BRAIN Initiative PI Meetings

Migraine Trainer

Owner

Kerry Gastley

Physician & Program Director

Adam Hartman

Engineering

Director, Office of Research Operations and Analysis

Anna Taylor

Deputy Director, Division of Extramural Activities

Ariel Zane

Program Director, Movement Disorders and Neurodegeneration

Beth-Anne Sieber

Brian Klein

Program and Project Management

Brooks Gross

Program Director

Carol Taylor-Burds

Marketing and Product

Charles Cywin

Brad Hennessie

Avindra Nath

Chief Section of Infections of the Nervous System, Director-Translational Neuroscience Center

Inhibikase Therapeutics is a developer of cellular Abelson tyrosine kinase inhibitors to treat infections and other diseases.

DTx Pharma is a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease.

Crinetics is a clinical-stage pharmaceutical company that develops therapies for people with rare endocrine diseases.

Acadia Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.

MediciNova is a  biopharmaceutical company that acquires and develops novel, small-molecule therapeutics.

Nexeon is a bioelectronics company developing and manufacturing medical devices and software platforms.

Acorda Therapeutics began in 1995 as a network of scientists, physicians and business people with a common belief.

Southern US Companies With More Than $100M in Revenue

Washington DC Metro Area Companies With More Than $10M in Revenue

East Coast Investors (Top 10K)

Grant Investors with Investments in San Francisco Bay Area

National Institute of Neurological Disorders and Stroke is a Medical trial health authority.

news impact assignment basic	general
public peers	general	Nov 15, 2024 1:52 PM	fe084995
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 15, 2024 1:52 PM	f47f1fae
crunchbase trigger	general	Nov 15, 2024 1:52 PM	24377f3b
crunchbase profile	general	Nov 15, 2024 8:25 PM	9c3802e8
li profile	general	Nov 15, 2024 1:52 PM	96f7d740
translate crunchbase fundingrounds	general	Nov 15, 2024 8:52 PM	4f3a3a0d
peers	general	Nov 15, 2024 1:52 PM	ea78f80c
news basic	general	Nov 15, 2024 1:52 PM	5e2cc85d
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

NIH

GOV:NIH:NINDS

National Institute of Neurological Disorders and Stroke